Rumi Scientific

About:

Rumi Scientific offers a flexible suite of services to complement its neuro-based research and drug discovery program.

Website: https://rumiscientific.com/

Twitter/X: rumisci

Top Investors: National Science Foundation, National Institute of Mental Health

Description:

Rumi Scientific is a research-based company dedicated to developing medications and novel treatments for human genetic illnesses of the central nervous system. It has created an interesting human organoid-based platform that may be used for drug discovery and high-throughput screening in a variety of situations. Rumi Scientific has developed a platform that replicates human development in vitro by combining genetic models of human diseases introduced by gene editing with multi-cellular self-organization to construct defined diseased embryonic tissues. This provides a basis for drug screening using artificial intelligence. By focusing on synthetic human embryology in both normal and disease contexts, the company aims to unlock new doors toward treatments for many genetic disorders that still have no cures.

Total Funding Amount:

$2.13M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)rumiscientific.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-06-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai